Seeking Alpha

Cephalon Inc. (CEPH)

()

News & PR
Market Currents

Buzz
Twitter: CEPH

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Spectrum Pharmaceuticals: The Labor Day Catalyst
Aug 20 • Justin M. Hall • BIIB, BYERF.PK, CEPH • 18 Comments
Wall Street Breakfast: Must-Know News
Oct 28 • SA Editor Eli Hoffmann • ACE, AMD, AMKR • 14 Comments
Wall Street Breakfast: Must-Know News
May 6 • SA Editor Rachael Granby • ACAS, AGU, ARM • 12 Comments
Wall Street Breakfast: Must-Know News
Feb 13 • SA Editor Rachael Granby • AAPL, AMKR, ANF • 11 Comments
Wall Street Breakfast: Must-Know News
Aug 5 • SA Editor Rachael Granby • AGU, AMZN, AUY • 11 Comments
Biotech Update: Arena Pharmaceuticals, Acusphere, Cephalon, ViroPharma, Auxilium
Nov 3, 2008 • Zacks.com • ACUS, ARNA, AUXL • 6 Comments
Hedge Fund Portfolio Tracking: Citadel Investment Group (Ken Griffin), Q3 2008
Jan 13 • Market Folly • AAPL, ACE, ADCT • 6 Comments
Wall Street Breakfast: Must-Know News
May 2, 2008 • SA Editor Eli Hoffmann • ADP, BEBE, BWA • 5 Comments
P/E - Value Plays or Value Traps?
Jul 12 • Value Expectations • BIIB, BMY, CBS • 5 Comments
Which CEO Is the Best Wealth Creator?
Jan 30 • Value Expectations • ABC, APOL, APU • 4 Comments
Lowest P/E Ratios in the Nasdaq 100
Jun 17, 2008 • Bespoke Investment Group • AMGN, CA, CDNS • 4 Comments
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
May 27 • Mark Cifra • ACOR, AGN, AMAG • 4 Comments
Biggest Money Makers and Losers Since 3/9/09
Oct 8 • TickerSense • AAPL, AZO, BEN • 4 Comments
S&P 500 Index: Six More Changes
Nov 12, 2008 • David I. Templeton • ASH, CEPH, GGP • 4 Comments
Cramer's Mad Money - Beating the Bad News Bears (3/13/09)
Mar 16 • SA Editor Miriam Metzinger • AAPL, AIPC, BAC • 4 Comments
Little Rays of Sunshine in the Markets
Feb 6 • Richard Shaw • CEPH, CHG, COCO • 3 Comments
BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte
Sep 25 • Mike Havrilla • CEPH, CHTP, CYTX • 3 Comments
2 Potential Pharma M&A Targets: Cephalon and Genzyme
Mar 23 • Bullish Bankers • BMY, CEPH, GENZ • 3 Comments
A Look at D.E. Shaw's Q408 Holdings: Just for Fun
Apr 22 • Market Folly • AAPL, ABII, ABT • 2 Comments
Friday Options Recap
Sep 4 • Frederic Ruffy • BCRX, CBST, CEPH • 2 Comments
Nasdaq 100 Stocks Up An Average of 20% YTD
May 20 • Bespoke Investment Group • AAPL, ADBE, APOL • 2 Comments
Ken Griffin's Citadel Fund: Options Eye Candy
Sep 10 • Market Folly • AAI, AAPL, AG • 2 Comments
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
Jul 1 • Mike Havrilla • AMAG, APPY, AZN • 2 Comments
How Pharma Is Faring in the Financial Crisis
Nov 14, 2008 • Mike Huckman • AMLN, BMY, CEPH • 2 Comments
Jim Cramer's Mad Money Lightning Round Picks 4/21
Apr 21, 2006 • AZN, BOW, CEPH • 2 Comments
Who Will Buy Spectrum Pharmacueticals?
Aug 6 • Mark Cifra • ABII, AGN, BYERF.PK • 2 Comments
Long/Short Hedge Strategy for Smaller Cap Stocks
Jan 5 • The Wall Street Transcript • APOL, CEPH, DLTR • 2 Comments
First Convertible Bond ETF Comes to Market
Apr 16 • Index Universe • AMGN, BAC, CEPH • 2 Comments
Fast Money Recap, 4/9/08: Airlines MayTake Off
Apr 10, 2008 • SA Editor Miriam Metzinger • AMR, ANR, APA • 1 Comment
The Biggest Losers
Sep 9 • Bespoke Investment Group • ABT, APOL, CEPH • 1 Comment

Cephalon Inc. (CEPH)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers